Related Experiment Video
Updated: Jun 10, 2026

Focal Laser Ablation of Prostate Cancer: An Office Procedure
Published on: March 30, 2021
ERG rearrangement is present in a subset of transition zone prostatic tumors
Sara M Falzarano1, Maria Navas, Kelly Simmerman
1Department of Anatomic Pathology, Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
Abstract:
A majority of prostate cancers exhibit a recurrent gene rearrangement involving chromosome 21. In approximately 90% of cases, the rearrangement is characterized by fusion of the androgen-regulated gene TMPRSS2 with the oncogene ERG. A recent study suggested that TMPRSS2-ERG gene fusion is lacking in cancers arising from the transition zone of the prostate. A dominant transition zone cancer was detected in 62/397 (16%) patients who underwent radical prostatectomy at our institution and were reviewed and mapped by a single pathologist. In 46/62 specimens, a secondary tumor was identified in the peripheral zone of the prostate. A tissue microarray containing both transition and peripheral zone tumors was constructed and evaluated for gene fusion analysis. TMPRSS2-ERG fusion status was determined using a multicolor interphase fluorescence in situ hybridization assay for ERG break-apart. The median age of the patients was 59 years. Prostatectomy Gleason score was 6 in 21, 7 in 34, and ≥8 in 7 cases. Median tumor volume was 200 mm(2). TMPRSS2-ERG gene fusion was present in 7/59 (12%) transition zone, and in 12/35 (34%) peripheral zone tumors. Transition zone fusion-positive cases were larger than their negative counterparts. No significant correlation was found between fusion status and Gleason score or pathologic stage. Gene fusion through deletion occurred in 4/7 transition zone and 7/12 peripheral zone tumors. Transition zone prostate cancers are considered biologically and genetically different from peripheral zone tumors. Although ERG rearrangement is more common in peripheral zone tumors, we have detected TMPRSS2-ERG fusion in a subset of transition zone cancers (12%). The lower frequency of gene fusion in transition zone prostate cancer may suggest distinct molecular alterations from peripheral zone tumors and the association with a high tumor volume may indicate a growth advantage for transition zone tumors harboring the gene fusion. Further studies are necessary to confirm this hypothesis.
Insights
TMPRSS2-ERG gene fusions, common in prostate cancer, were found in 12% of transition zone tumors, unlike previous suggestions. These fusion-positive transition zone cancers were larger, suggesting distinct molecular pathways.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Prostate cancer frequently involves TMPRSS2-ERG gene fusions, typically originating from the peripheral zone.
- Previous research suggested TMPRSS2-ERG fusions are absent in prostate transition zone cancers.
Purpose of the Study:
- To investigate the presence and characteristics of TMPRSS2-ERG gene fusions in prostate transition zone tumors.
- To compare fusion status between transition zone and peripheral zone prostate cancers.
Main Methods:
- A tissue microarray was constructed from radical prostatectomy specimens containing both transition and peripheral zone tumors.
- TMPRSS2-ERG fusion status was assessed using multicolor interphase fluorescence in situ hybridization (FISH) for ERG break-apart.
Main Results:
- TMPRSS2-ERG gene fusion was detected in 12% of transition zone tumors (7/59) and 34% of peripheral zone tumors (12/35).
- Transition zone tumors with TMPRSS2-ERG fusion were significantly larger than fusion-negative counterparts.
- No correlation was observed between fusion status and Gleason score or pathological stage.
Conclusions:
- Prostate transition zone cancers can harbor TMPRSS2-ERG gene fusions, albeit at a lower frequency than peripheral zone tumors.
- The presence of TMPRSS2-ERG fusion in transition zone cancers may indicate distinct molecular alterations and a potential growth advantage.
- Further research is warranted to elucidate the specific molecular mechanisms and clinical implications.
Related Concept Videos
[3,3] Sigmatropic Rearrangement of 1,5-Dienes: Cope Rearrangement
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Preparation of 1° Amines: Hofmann and Curtius Rearrangement Overview
Thermal Sigmatropic Reactions: Overview
Sigmatropic shifts are classified based on an order term [i, j ], where i and j indicate the number of atoms across which each end of the σ bond migrates. Below are examples of a [3,3] sigmatropic shift in 1,5-hexadiene, referred to as...
[3,3] Sigmatropic Rearrangement of Allyl Vinyl Ethers: Claisen Rearrangement

